Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
about
Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis. Alpha-1 protocolAlpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strainsAcute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsExpanding the clinical indications for α(1)-antitrypsin therapyAlpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes.Assessment of gene-by-sex interaction effect on bone mineral densityα1Proteinase inhibitor regulates CD4+ lymphocyte levels and is rate limiting in HIV-1 diseaseElevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionA comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replicationMonocyte CD49e and 110-120 kDa fibronectin fragments: HIV prognostic indicators independent of viral load and CD4 T-cell countsα1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.Slow human immunodeficiency virus (HIV) infectivity correlated with low HIV coreceptor levelsA review of augmentation therapy for alpha-1 antitrypsin deficiency.In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitinationα1-Antitrypsin activates protein phosphatase 2A to counter lung inflammatory responses.Comparative proteomic study reveals the molecular aspects of delayed ocular symptoms induced by sulfur mustardAlpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.Serum protein electrophoresis under effective control of HIV-1 disease progression.Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cellsPeptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.Low-density lipoprotein receptor-related protein 1 mediates α1-antitrypsin internalization in CD4+ T lymphocytes.Role of lung maintenance program in the heterogeneity of lung destruction in emphysema.A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression.α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke.α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-αAnti-inflammatory Agents: Present and FutureAlpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole bloodAnti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collectionAlpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cellsLung disease associated with alpha1-antitrypsin deficiency.Airway disease in alpha-1 antitrypsin deficiency.The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV.Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
P2860
Q23911017-08E01CF8-7F6D-426B-BDD8-E5B144DA0758Q24299950-19515B7C-037E-48C7-AD41-D107A2156EE8Q26858837-0C59D74E-C3B8-42F6-B88B-A2113770676DQ27000764-9DF7D5E9-D6C7-4556-B1BF-31685BDCB0C1Q27316160-6F204F3F-3A72-4B7B-B3EA-67BB6094A40AQ28727687-6B1DD548-920B-4C16-BC2B-436F4F0F517EQ28731975-1257EC2D-6E3B-423B-B329-E58EB4A98FDCQ33576664-3D449764-EFCD-4E48-8F0C-373C4A8668B6Q33825756-DFD88DD4-715B-48D9-A6D1-E4EA0664B449Q33886860-752A43A3-DF6B-4095-9B40-2D17E42E15D3Q33914564-5C3DBAE7-F676-45AD-B325-CEE6AE22A5E5Q33999020-BFB9B4F6-F188-41F2-8079-62443284F075Q33999446-BB95B8BD-9AAB-4C5B-BB30-60A683C0406EQ34268108-7CF2BBF8-EF76-4C88-A0B5-B138C33601B4Q34469655-185E4092-FF69-401E-A6EC-3077903E3BF9Q34700076-04290E4D-EA2F-4F10-907C-3EA30A72D106Q34980209-F18D35F9-015C-48BD-AA4D-2B9C4695204AQ35006041-0E56C4F4-F84A-4372-91BD-9726F53DF996Q35044708-B1B570F1-A0BA-42E1-A3D0-D89459DDDFE8Q35562012-02DCE32F-CD26-4EE2-9EB6-01D67676C433Q35673668-13773B64-9043-4FF4-AAEA-F9900F954541Q35728932-D6CD90C4-A72D-4E1A-A97F-7DF027DAC09EQ35773708-38106A11-829E-42A4-8383-597B4D4E6A1DQ35913894-517C1615-156E-4207-8B80-45D3FD004D9CQ35959814-B92AEFB8-A753-44FE-BC15-112A46E108D3Q36108116-7D0A3354-2723-4D51-B65D-4BB919272662Q36607648-5BB18191-D670-4301-8604-EBA68DBCAC59Q36634711-861466D2-2F5B-43DD-97BD-2D0BFD1979C5Q36759980-CA2CE226-EADD-4F37-B2F3-A6486FA9DC87Q37012186-B956E860-670C-43C9-8083-ECC1A023F474Q37056456-FFAEC1F0-FF61-4F43-ADE3-EB8DBA6B9EF0Q37118156-A5D4C18B-5220-4368-8602-65A3C29D90E7Q37159126-11B4B75C-C221-4EBA-A843-B7926420A662Q37173117-D5E35CED-1B1B-4304-ACF9-59A6BC685C5EQ37309287-68EB65A6-25F6-41A4-B11B-3547D18A2845Q37372512-F9310424-7452-47BD-8388-20140BF14A1CQ37804626-C9989F72-664D-4921-A282-EA9213BB6C82Q38092905-3F41A561-DABC-46F5-93C7-01D9FE663A03Q38170193-26DFA93D-472D-4193-802E-FB11159B12E4Q38365800-EE8FDDE5-B4E9-41D7-8AA6-FC1620898364
P2860
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
@ast
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
@en
type
label
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
@ast
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
@en
prefLabel
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
@ast
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
@en
P2093
P356
P1433
P1476
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.
@en
P2093
P304
P356
10.1096/FJ.00-0311COM
P407
P577
2001-01-01T00:00:00Z